These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28646433)

  • 21. [Oxcarbazepine in the treatment of epilepsy].
    Freidel M; Krause E; Kuhn K; Peper R; Vogel H
    Fortschr Neurol Psychiatr; 2007 Feb; 75(2):100-6. PubMed ID: 17200915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical recommendations for oxcarbazepine.
    Smith PE;
    Seizure; 2001 Mar; 10(2):87-91. PubMed ID: 11421225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures.
    Piña-Garza JE; Espinoza R; Nordli D; Bennett DA; Spirito S; Stites TE; Tang D; Sturm Y
    Neurology; 2005 Nov; 65(9):1370-5. PubMed ID: 16275822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxcarbazepine: a review of its use in children with epilepsy.
    Bang L; Goa K
    Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of topiramate in childhood generalized seizure disorders.
    Wheless JW
    J Child Neurol; 2000; 15 Suppl 1():S7-13. PubMed ID: 11218056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study.
    Villanueva V; Montoya J; Castillo A; Mauri-Llerda JÁ; Giner P; López-González FJ; Piera A; Villanueva-Hernández P; Bertol V; Garcia-Escrivá A; Garcia-Peñas JJ; Garamendi I; Esteve-Belloch P; Baiges-Octavio JJ; Miró J; Falip M; Garcés M; Gómez A; Gil-López FJ; Carreño M; Rodriguez-Uranga JJ; Campos D; Bonet M; Querol R; Molins A; Tortosa D; Salas-Puig J
    Epilepsia; 2018 Sep; 59(9):1740-1752. PubMed ID: 30062784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures.
    Sachdeo R; Beydoun A; Schachter S; Vazquez B; Schaul N; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2001 Sep; 57(5):864-71. PubMed ID: 11552018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retention rate of oxcarbazepine monotherapy in an unselected population of adult epileptics.
    Rainesalo S; Peltola J; Auvinen A; Keränen T
    Seizure; 2005 Jan; 14(1):72-4. PubMed ID: 15642505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spotlight on oxcarbazepine in epilepsy.
    Bang LM; Goa KL
    CNS Drugs; 2004; 18(1):57-61. PubMed ID: 14731060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of low to moderate doses of oxcarbazepine in adult patients with newly diagnosed partial epilepsy.
    Zou XM; Chen JN; An DM; Hao NY; Hong Z; Hao XT; Rao P; Zhou D
    Seizure; 2015 Jul; 29():81-5. PubMed ID: 26076847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical effects of topiramate against secondarily generalized tonic--clonic seizures.
    Wang Y; Zhou D; Wang B; Kirchner A; Hopp P; Kerling F; Pauli E; Stefan H
    Epilepsy Res; 2002 Apr; 49(2):121-30. PubMed ID: 12049800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Side-to-side axial movements. Adding a new sign to the asymmetry of the clonic phase and asymmetric seizure termination in differentiating primary and secondarily generalised tonic-clonic seizures.
    Franca S; Gupta DK; Rao S; Pestana E; Freitas J; Loplumlert J; Lhatoo SD
    Epileptic Disord; 2014 Mar; 16(1):1-4. PubMed ID: 24691293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures.
    Biton V; Sackellares JC; Vuong A; Hammer AE; Barrett PS; Messenheimer JA
    Neurology; 2005 Dec; 65(11):1737-43. PubMed ID: 16344515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxcarbazepine: an update of its efficacy in the management of epilepsy.
    Wellington K; Goa KL
    CNS Drugs; 2001; 15(2):137-63. PubMed ID: 11460891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies.
    Rektor I; Krauss GL; Inoue Y; Kaneko S; Williams B; Patten A; Malhotra M; Laurenza A; Wechsler RT
    Epilepsia; 2020 Jul; 61(7):1491-1502. PubMed ID: 32645213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxcarbazepine in the treatment of childhood epilepsy.
    Serdaroglu G; Kurul S; Tutuncuoglu S; Dirik E; Sarioglu B
    Pediatr Neurol; 2003 Jan; 28(1):37-41. PubMed ID: 12657418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precipitating factors and therapeutic outcome in epilepsy with generalized tonic-clonic seizures.
    Bauer J; Saher MS; Burr W; Elger CE
    Acta Neurol Scand; 2000 Oct; 102(4):205-8. PubMed ID: 11071103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N; Jones J; Tonner F
    Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial.
    French JA; Krauss GL; Wechsler RT; Wang XF; DiVentura B; Brandt C; Trinka E; O'Brien TJ; Laurenza A; Patten A; Bibbiani F
    Neurology; 2015 Sep; 85(11):950-7. PubMed ID: 26296511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.